Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell Transplantation

Published:2024-06-01 Issue:6 Volume:44 Page:
ISSN:0271-9142
Container-title:Journal of Clinical Immunology
language:en
Short-container-title:J Clin Immunol

Author:

Siblany Lama,Stocker Nicolas,Ricard Laure,Brissot Eolia,Duléry Rémy,Banet Anne,Sestili Simona,Belhocine Ramdane,Van de Wyngaert Zoé,Bonnin Agnès,Capes Antoine,Ledraa Tounes,Beurier Pauline,Fadel Karen,Mohty Mohamad,Gaugler Béatrice,Malard Florent

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10875-024-01741-6.pdf

Reference17 articles.

1. Andrlova H, van den Brink MRM, Markey KA. An unconventional view of T cell reconstitution after allogeneic hematopoietic cell transplantation. Front Oncol. 2020;10:608923. https://doi.org/10.3389/fonc.2020.608923.

2. Mori L, Lepore M, De Libero G. The immunology of CD1- and MR1-restricted T cells. Annu Rev Immunol. 2016;34:479–510. https://doi.org/10.1146/annurev-immunol-032414-112008.

3. Treiner E, Duban L, Bahram S, Radosavljevic M, Wanner V, Tilloy F, Affaticati P, Gilfillan S, Lantz O. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature. 2003;422(6928):164–9. https://doi.org/10.1038/nature01433.

4. Rudak PT, Choi J, Haeryfar SMM. MAIT cell-mediated cytotoxicity: Roles in host defense and therapeutic potentials in infectious diseases and cancer. J Leukoc Biol. 2018;104(3):473–86. https://doi.org/10.1002/JLB.4RI0118-023R.

5. Sandstrom A, Peigne CM, Leger A, Crooks JE, Konczak F, Gesnel MC, Breathnach R, Bonneville M, Scotet E, Adams EJ. The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vgamma9Vdelta2 T cells. Immunity. 2014;40(4):490–500. https://doi.org/10.1016/j.immuni.2014.03.003.